in this issue
Regions :: North America :: U.S.
SAFC signs API development deal with Korean firm
6:41 AM MDT | October 30, 2012 | Deepti Ramesh
Sigma-Aldrich Fine Chemicals (SAFC), the custom manufacturing and services business unit of Sigma-Aldrich, says it has signed an agreement with CrystalGenomics (Seoul) to support the development of active pharmaceutical ingredients (APIs) for next-generation non-steroidal anti-inflammatory drugs (NSAID). The agreement represents SAFC's first pre-formulation services contract into the growing Korean pharmaceutical market, the company says. CrystalGenomics is a clinical stage biopharmaceutical company that is involved in the discovery and development of innovative...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee